• Mashup Score: 1

    Nathan E. Welty and Saar I. Gill J Am Coll Cardiol CardioOnc. 2022 Dec, 4 (5) 563–578. J Am Coll Cardiol CardioOnc. 2022 Dec, 4 (5) 579–597. Giselle Alexandra Suero-Abreu, Tomas G. Neilan, et. al. J Am Coll Cardiol CardioOnc. 2022 Dec, 4 (5) 598–615. J Am Coll Cardiol CardioOnc. 2022 Dec, 4 (5) 616–623. Franck Thuny, Jennifer Cautela, et. al. J Am Coll Cardiol Cardi oOnc. 2022 Dec, 4 (5) 624–628. J Am Coll Cardiol CardioOnc. 2022 Dec, 4 (5) 629–634. Megan Mulholland, Daniel Engelbertsen, et. al. J Am

    Tweet Tweets with this article
    • Enjoying the #ESCCongress session on emerging #biomarkers in cardiology happening now? Check out our related #JACCCardioOnc special issue for more resources: https://t.co/M6Akr6o0W0 #CardioTwitter #CardioOnc #ImmuneTherapy https://t.co/yICtTf2Uek

  • Mashup Score: 0

    Home > GI Cancer > Study Identifies Platelet-Derived circRNAs as Biomarkers in Patients With GEP-NETs For the first time, researchers identified a circular RNA (circRNA) signature from tumor-educated platelets (TEPs) as a potential diagnostic and predictive biomarker for gastroenteropancreatic neuroendocrine tumors (GEP-NETs). Their findings were published in the Journal of Translational Medicine. According to researchers, early diagnosis of NETs “is a clinical challenge that requires a deep understanding

    Tweet Tweets with this article
    • Researchers identified a circRNA signature as a potential biomarker for gastroenteropancreatic neuroendocrine tumors, also known as GEP-NETs. #gioncology #biomarkers #gastriccancer https://t.co/ZhyQDNfgfp https://t.co/VW6wqYIlCt

  • Mashup Score: 0

    The identification of cardiovascular (CV) diseases before their clinical manifestation is supposed to be a very useful tool to better stratify and manage the CV

    Tweet Tweets with this article
    • The identification of cardiovascular diseases before their manifestation is an evolving field. Which future for the research with advanced imaging technology and biomarkers? https://t.co/EyZzyCLuMM @h_hellmut #biomarkers #imaging #CAD #cardiotwitter @ESC_Journals @escardio https://t.co/he2j0REDGw

  • Mashup Score: 1

    Objective IBD therapies and treatments are evolving to deeper levels of remission. Molecular measures of disease may augment current endpoints including the potential for less invasive assessments. Design Transcriptome analysis on 712 endoscopically defined inflamed (Inf) and 1778 non-inflamed (Non-Inf) intestinal biopsies (n=498 Crohn’s disease, n=421 UC and 243 controls) in the Mount Sinai…

    Tweet Tweets with this article
    • #GUTImage from the paper by Argmann et al entitled "Biopsy and blood-based molecular biomarker of inflammation in IBD" via https://t.co/pA64R32Zjd #IBD #Biomarkers @JeanFredericCo1 https://t.co/NRgOqvzHLT

  • Mashup Score: 2

    Accept Cookies & Privacy Policy? This website uses cookies to ensure the best possible web experience. By continuing and using the site, you consent to the use of cookies. If you wish to disable them or to learn more about how we use cookies, please view our Cookies Policy. …

    Tweet Tweets with this article
    • Are you or a colleague doing cutting-edge work on #biomarkers, #BOS, or #ddcfDNA?Don't miss the opportunity to apply for NEW 2023 #ISHLTResearchGrants. 📅You have until the end of Sep to apply! 🔗https://t.co/Q3zlmjTWpf #ISHLT #HeartTx #LungTx https://t.co/hOIi2pp8nN